Navigation Links
PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial
Date:3/10/2008

sis has been granted Fast Track designation and orphan drug status in the United States by the FDA and orphan drug designation in Europe by the European Medicines Agency (EMEA).

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufacturers the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI's Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at http://www.Pari.com


'/>"/>
SOURCE PARI Respiratory Equipment, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Scientists pinpoint protein link to fat storage 9969 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 2Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 3Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 4Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 1Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 2Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 3Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 4
...ificantly Improved Key PSG Parameters of Sleep Mai...tudy Ongoing -, SAN DIEGO, June 12 Arena Pharmac...t Dr. Thomas Roth of Henry Ford,Hospital presented...l of,APD125 for the treatment of insomnia in an or...ing of the Associated Professional Sleep Societies...
...GAITHERSBURG, Md., June 12 ,Micromet, Inc. (Nasdaq...irst,patient has started treatment in a multi-cent...ng BiTE(R) antibody blinatumomab (MT103/MEDI-538) ...a (ALL). Blinatumomab is a T,cell engaging antibod...sed,on B cells. The clinical development program f...
Other Medicine Technology:Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 3Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 4Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 5Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 6Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBartle...,slargestmedicalcliniconDec.9-10,whenKansasCityhos...edpeople. ,, "Thisfreecliniceventhasthepotentia...ysinsteadofjustoneandbeheldonweekdaysinsteadofover...tyFreeHealthClinicandpresidentoftheNationalAssocia...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...Researchers have found evidence of a statistically...fen among patients whose estrogen receptor (ER)-po...f ER-alpha; at serine-118 (ER-alpha S118-P), accor...ember 25 in the Journal of the National Cancer In...as are resistant to tamoxifen. Preclinical studies...
(Date:11/25/2009)... Evaluation and treatment c... Woodstock (Vocus) November 25, 2009 -- C...nasal vaccines and H1N1 vaccine shots at four Cent...another shipment of vaccine has arrived. The clini... Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/-...reventHealthCareFraudActof2009,"S.2128,whichisdesi...letopreventfraudinMedicare.ThebillwasintroducedbyS...ainsseveralprovisionstheAmericanAssociationforHome...htheAssociationproposedtoCongressinFebruary.Thosep...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...culture had found out a soluble ingredient which w...sorption of the fat at a healthier level. Another ...luble cellulose, reduces the probability of develo... as the one that adds texture. The use of this ing...
...ation (WHO) the apex medical body warns the people... avian influenza or bird flu virus in the area. I... to provide full information to WHO regarding new ... complete the ongoing assessment of the nature of ...
... by Teva Pharmaceutical Industries Ltd. is said to...disease. According to the latest investigatio... physical abilities of patients suffering from Par...ease the extent of motor activities for the patien...
...ription could be used to avoid medical mistakes, b...// may lead to even more errors. It is known th...0,000 people in hospitals each year. One way hospi...ms may actually be leading to more mistakes. Th...
...ther antihypertensive strategies that use calcium ...r to older treatments with beta-blockers and diure... calcium channel blocker amlodipine with or withou... was prematurely stopped after concerns arose that...
...the most common form of brain cancer might fare be...motherapy than radiotherapy alone . Based on fi...ith the type of cancer known as glioblastoma recei...as who were randomized to receive either radiother...
Other Medicine News:
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
AST-GOT
...-line worker" for routine staining protocols frequ...s. It automatically stains big quantities of slide...of reagent stations in combination with a continuo...p to 12 baskets with 30 slides each can be process...
MS/DS 50/100 Slide Stainer
Medicine Products: